Surgery is recommended following endoscopic polypectomy for malignant adenoma (MA) in the large bowel in patients with risk factors for tumor recurrence or distant metastasis are present.
which poses a risk for cancer dissemination. Endoscopic polypectomy of MA is considered adequate if all of the following criteria are met: excision was complete in the opinion of an endoscopist, the cancer-free resection margin is at least 2 mm (1 mm according to some authors), the tumor is well-differentiated (G1 or G2), and no invasion of the venous or lymphatic vessels is observed.
4-14 Also, the depth of invasion should not exceed the head of the polyp in stalked polyps or be no greater than one-third of the submucosa INTRODUCTION (STROBE 2,3) Malignant adenoma (MA) in the large bowel is an adenoma in which neoplastic cells cross the lamina muscularis mucosa and infiltrate the submucosa of the intestinal wall, but not the lamina muscularis propria.
1
Asymptomatic MAs are increasingly detected during screening colonoscopy, and various endoscopic techniques are being studied that may help increase detection rates for adenoma.
2,3 From an oncological point of view, MA is an irreversible stage in the adenoma-carcinoma sequence, it increased to 12% 21 (STROBE 2). In light of the recent studies, laparoscopic surgery should be recommended as the first-choice technique in colon cancer because, compared with open surgery, it poses a lower risk of short-term complications and provides equivalent long-term oncological outcomes. Whether the same is true for rectal cancer surgery is yet uncertain. 20 The primary aim of the present study was to prospectively evaluate long-term outcomes in patients who underwent endoscopic polypectomy for sporadic MAs in a single reference endoscopy center. The secondary aim was to assess retrospectively whether a reduction in the tumor-free resection margin from 2 mm to 1 mm or adding a tumor budding criterion influences the long-term results of treatment (STROBE 3). The study protocol and inclusion/exclusion criteria, first defined in 1979, have remained unchanged over time. Endoscopic polypectomy was considered adequate if the following criteria were met: excision was complete in the opinion of the endoscopist; the histological tumor-free resection margin was at least 2 mm; the tumor was well-differentiated (G1 or G2); and there was no invasion of the venous or lymphatic vessels. Patients in whom endoscopic removal was not performed due to macroscopic features suggesting carcinoma (eg, ulceration, firm tumor, nonlifting sign), patients with inflammatory bowel disease or known familial polyposis syndromes (ie, Lynch syndrome and familial adenomatous polyposis), and patients with concomitant disseminated neoplastic diseases were excluded from the study (STROBE 6A,9,10). In 1994, the study was approved by the institutional review board in accordance with the guidelines of the Helsinki Declaration revised in 1989.
PATIENTS AND METHODS (STROBE
Standard endoscopic polypectomy Polyps were removed using standard polypectomy techniques. When pedunculated polyps were removed, the cut was made in the lower one-third of the stalk of the polyp. Sessile polyps were removed in one piece whenever possible. After 1994, any polyp remnants visible after application of the diathermic loop were completely destroyed by argon plasma coagulation. When a piecemeal technique was used, the site of polypectomy was tattooed for easier further localization during surveillance colonoscopy. Diluted India ink was injected through an injection needle at an oblique angle tangential to the colon wall and targeted to the submucosal layer of the interhaustral folds on the anal side of the lesion (3 injections). In the report, thickness in nonpedunculated polyps. 15,16 Tumor budding is another possible poor prognostic factor following endoscopic polypectomy of MA. 11, 17 This phenomenon is indicated by the presence of isolated crypts, microscopic clusters of cells, or undifferentiated cancer cells at the invasion front (FIGURE 1).
If at least one of the established criteria for adequate endoscopic polypectomy is not fulfilled, the risk of lymph node metastasis reported in case series is from 3.5% to even 35.7%, depending on the polyp morphology, 18-20 which is high enough to recommend an additional surgical resection of the involved bowel fragment with adjacent lymph nodes. Before the decision on the surgery is made, another independent pathologist should reassess the resected polyp. Also, complete colonoscopy should be performed to exclude the presence of possible synchronous lesions, which may affect the extent of bowel resection. The site of the polypectomy should be tattooed to facilitate its identification during surgery. However, patients who underwent surgery as an adjuvant treatment were found to have similar rates of metastasis to patients who were only followed up (5.8% and 8.9%, respectively), as well as similar death rates for colorectal cancer (6.6% and 10.1%, respectively). 6 In a large population-based sample, more than one-third of the patients with malignant polyps were treated solely with colonoscopic polypectomy, and the outcomes (1-year and 5-year risk of death) in this group were similar to those of surgical patients with comparable clinical characteristics.
14 Surgery is associated with a substantial risk of severe complications, 9 or even death. 19 The authors of a recent population-based study from England analyzed the results of all providers of major colorectal cancer surgery within the English National Health System in the years 1998-2006. In high-volume reference centers, the risk of death related to the bowel surgery was from 2% to 5%.
21 In individuals younger than 65 years of age, the risk was close to zero, but in those over 70 years of age, MA with and without budding was compared using the Fisher exact test. 10,13A,B,C,14A,B,C,15,16,17) Of 147 patients potentially eligible for the study, 19 were excluded: lost an original full histological report (n = 3 in the 1990s), did not consent to continued follow-up (n = 9), or presented with a different disseminated neoplasm treated with radiotherapy or chemotherapy (or both) at the diagnosis of MA (n = 7). The remaining 128 patients (63 women, 65 men; age, 42-88 years; median, 64 years) fulfilled the inclusion and exclusion criteria for the study. A total of 130 MAs were endoscopically removed from those patients (STROBE 10,13A,B,14A) . The median postpolypectomy follow-up was 70.4 months (STROBE 14C). The study flowchart is presented in FIGURE 2 (STROBE 13C).
RESULTS (STROBE
General outcomes The endoscopic and histopathological features of the resected polyps are presented in Low-risk patients Endoscopic polypectomy was regarded as adequate in 61 patients with 63 MAs, to whom follow-up was recommended. This recommendation was accepted by 57 patients, who were followed up for a median of 69.2 months (interquartile range [IQR], 44.2-86.7 months); 52 (85.2%) were followed up for at least 5 years. In this group, no unfavorable outcomes of endoscopic treatment were observed. In the remaining 4 patients, the surgery was performed: 2 patients had bowel perforation following polypectomy and 2 patients requested the operation. No cancer infiltration or lymph node metastases were found in the surgical specimens from these patients (STROBE 16,17).
High-risk patients At least 1 high-risk criterion was present in 67 patients with 67 MAs, to whom surgical resection of the affected bowel segment with regional lymph nodes was recommended. However, only 32 patients underwent the operation. Operations were open procedures and involved hemicolectomies, segmental resections, and 1 local excision of a lesion in the rectum. Twenty-seven of these patients were followed for a median of 71.9 months (IQR, 50.7-97.3 months), and the treatment outcome was good in 27 of 32 patients (84.3%). Unfavorable outcomes were observed in 5 of 32 patients (15.6%): the distance of the polypectomy/tattoo site from the anal verge was included. The location and diameter of each polyp was noted and postpolypectomy complications were recorded (STROBE 8).
Histopathology All the removed tissue was subject to a histopathological examination. The specimens were fixed in formalin, embedded in paraffin, and stained with hematoxylin and eosin. The specimens were sectioned along the long axis of the polyp to examine it from the head to base. The pathologist assessed the tumor grade, presence of cancer cells in blood and lymphatic vessels, and the distance between the cut line and the (radial) tumor margin. Basically, a distance of 2 mm or more was regarded as adequate. In addition, 85 polyps that were still available for a histological assessment at the time of the final analysis were used for a retrospective assessment of tumor budding and 1-mm tumor-free margin (≥1 mm criterion met or not met) by a single experienced GI pathologist (DJ) (STROBE 8).
Further management Each patient was informed about the result of the microscopic examination and given recommendations based on the magnitude of risk (low or high) following the endoscopic treatment. The risk of dissemination was discussed in each case, and the risk of surgical complications and mortality presented. Patients at high risk of an unfavorable outcome (at least 1 criterion not met) were recommended for surgery, whereas patients at low risk (all criteria met) were recommended for follow-up. The follow-up consisted of regular outpatient visits, colonoscopy (with tattooing the polypectomy site if it was not done earlier and the site was still identifiable), abdominal ultrasonography, and an estimation of the carcinoembryonic antigen level every 3 months during the first year, every 6 months during the second year, and annually up to 5 years following the polypectomy. Further follow-up was irregular, but usually at 1-year intervals (STROBE 6A).
Unfavorable outcomes An unfavorable outcome of the endoscopic polypectomy was defined as the occurrence of 1 or more of the following: presence of cancer or adenoma in the surgical specimen from a patient who underwent surgery; lymph node metastasis in the surgical specimen from a patient who underwent surgery; local recurrence of cancer or adenoma confirmed by histopathology; presence of distant colorectal cancer metastasis; and death due to colorectal cancer dissemination (STROBE 7).
Statistical analysis (STROBE 11,12)
The primary analysis covered long-term outcomes in patients with MA. The secondary analysis involved the assessment of long-term outcomes according to conventional versus modified criteria for adequate endoscopic polypectomy of MA. The frequency of unfavorable outcomes in patients with (n = 4) and death due to colorectal cancer (n = 1) (STROBE 16,17).
Complications of endoscopic treatment Two episodes of bleeding during polypectomy and one episode of delayed bleeding were observed (2.3% of polypectomies); all were treated endoscopically with success. Two perforations occurred, one immediate and one delayed, and the patients were treated by surgery; one of them required reoperation due to surgical complications. No deaths occurred.
Analysis of the outcomes using ≥1 mm tumor-free margin (STROBE 17) The tumor-free margin was reassessed in 85 polyps from 85 patients to examine whether reducing the margin from ≥2 mm to ≥1 mm affected the outcome (FIGURE 3). All 44 patients who fulfilled the adjusted tumor-free margin criterion and had no other high-risk factors showed good outcomes, regardless of whether cancer infiltration in the surgical specimen (n = 1), cancer infiltration and metastasis in regional lymph nodes in the surgical specimen (n = 1), high-grade dysplasia in the surgical specimen (n = 1), cancer metastasis in regional lymph nodes in the surgical specimen (n = 1), and cancer recurrence in lymph nodes during follow-up (n = 1) (STROBE 16,17) .
The remaining 35 patients from this group did not undergo surgery. The median age in this group was 69 years, 12 years older than the patients who underwent surgery; 12 patients (34%) were 75 years or older. The reasons for abstaining from surgery were: high risk due to concomitant diseases (n = 15), another synchronous malignancy (n = 5), and the lack of patient's consent (n = 15). Despite not undergoing surgery, 30 patients in this group had good long-term outcomes (30/35, 85.7%). Unfavorable outcomes that occurred in the other 5 patients were due to cancer recurrence at the site of polypectomy 
FIGURE 3
Results of follow-up in 85 patients with endoscopically removed malignant adenoma(s), reclassified according to the modified criteria for adequate polypectomy (≥1 mm tumor-free margin, G1-G2 differentiation rate, and no angioinvasion) usually present in polyps with tumor budding: <2 mm tumor-free margin (12 of 17 patients, 70.6%), poor (G3) differentiation grade of cancer (1 of 17 patients, 6%), and angioinvasion (6 of 17 patients, 35.3%). In the 68 polyps without tumor budding, these percentages were lower: 35.3%, 0%, and 14.7%, respectively. The follow-up in this subgroup did not reveal significant differences in long-term outcomes between patients with and without tumor budding (TABLE 4) .
DISCUSSION (STROBE 18,19,20,21)
We have shown good long-term outcomes in a group of patients who underwent endoscopic polypectomy for MA and were conservatively followed up or underwent surgery depending on the detailed histopathology results and patients' health and preference. Unfavorable outcomes were observed in 7.8% of the patients with 1 or more high-risk factors. Similar results were reported in earlier studies but with fewer patients or shorter follow-up. 4,6,7,11,12,18,22-25 These studies showed that endoscopic polypectomy is an effective and safe method of treating the majority of MAs. In the present study, we have also shown, based on the long-term follow-up, that this treatment provides oncological safety in those who fulfill the established criteria for adequate polypectomy. What conservative follow-up or surgery was performed. Forty-one patients did not fulfill the modified criteria and would have been recommended surgery. Twenty patients would have had the operation, 16 of whom would have good long-term outcomes. Unfavorable outcomes would have occurred in 4 patients. In the subgroup of 21 patients who would not undergo the recommended surgery, good results would have been observed in 18 and failure of the endoscopic treatment in 3 patients. Essentially, these outcomes are similar to the outcomes obtained with the use of the conventional criterion of ≥2 mm. Importantly, applying the modified tumor-free margin criterion would have resulted in transferring 6 patients from the group referred for surgery to the group recommended for follow-up alone, in which case the conservative management would have been recommended to the majority of the patients (TABLE 3) . These additional 6 patients had good long-term outcomes.
The effect of tumor budding (STROBE 17)
Tumor budding was present in 17 of the 85 examined MAs (20.9%). Unfavorable outcomes occurred in 2 of these patients (11.7%) and in 5 (7.3%) who were negative for tumor budding (P >0.05, Fisher exact test). The other high-risk factors were Association between tumor budding and regional lymph node involvement has been observed in advanced colorectal cancer. 27-29 Studies of early cancer had similar results, though mainly in patients treated by surgery.
11,30-32 Our analysis showed that, in cancers with tumor budding, the other high-risk factors are more common compared with cancers without this sign. However, we failed to show a distinct association between tumor budding and unfavorable outcomes. In our series, adding this sign to the conventional criteria for adequate polypectomy did not affect recommendations regarding postpolypectomy management or long-term outcomes (STROBE 20,21) .
The present study has the following limitations. First, this was a single-center study performed in a center of excellence specializing in the advanced techniques of polypectomy. Therefore, good results may not be reproducible in real life. Second, the study included patients over a long period of time, starting in 1979, when not all current methodologies were available (eg, argon plasma coagulation, videocolonoscopes, etc.); thus, methods for polyp assessment and removal might not have always been up-to-date. On the other hand, these limitations also represent the strengths of the study, as we kept the basic protocol, and the polypectomy techniques remained relatively unchanged; therefore, they could be fully assessed (STROBE 19,21 ).
Conclusions
Our long-term follow-up of 128 patients confirmed the efficacy and oncological safety of adequate endoscopic polypectomy for MA. Reducing the tumor-free margin from ≥2 mm to ≥1 mm may increase the number of patients for whom the conservative approach is recommended instead of bowel surgery.
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In the present series, the proportion of patients in whom the tumor-free margin criterion of ≥2 mm was not fulfilled was high (45%), and identification of those patients in the subgroup with a particularly high risk of cancer dissemination is important. According to previous reports, residual cancer tissue at the polypectomy site was found in 10% to 30% of the patients with too narrow a tumor-free margin. 6,10,12 In our study, among 26 patients who did not fulfill the ≥2-mm tumor-free margin criterion and underwent surgery, residual cancer was found only in 2 cases (7.7%): at the polypectomy site in 1 patient and in the regional lymph nodes in the other. This finding suggests that more than 90% of the patients who did not fulfill the tumor-free margin criterion could have safely avoided the surgery. Similarly positive results have already been presented by other authors. 6,12,14,26 In a recent study by Ikematsu et al., 26 a higher recurrence rate was observed in patients with endoscopically resected rectal cancer compared with colon cancer, but this was not the case in our study, as the proportion of rectal MAs (22.5%) and the proportion of rectal MAs among the patients who had negative outcomes (20%) were similar.
Though the importance of the tumor-free margin is not debatable, the authors differ in terms of what should be considered a safe width. Both the ≥2-mm and ≥1-mm margins are accepted. 5, 8, 22, 26 Other definitions of adequate polypectomy in the literature include "complete polypectomy" or "no cancer infiltration in the cut line".
25
However, the coagulation current destroys tissues below the cut line. On the other hand, coagulation features in the cancer infiltration zone have been related to a significant (up to 50%) risk of local cancer recurrence and the presence of residual cancer tissue at the site of polypectomy (13%).
11 In the present study, a change in the tumor-free margin criterion from ≥2 mm to ≥1 mm did not deteriorate the outcome. In a subgroup of patients with ≥1-mm margins who had no other risk factors, no treatment failure was observed. Using this modified criterion would have allowed to avoid surgery in 13% of the patients, as they would have been recommended a conservative follow-up instead. Thus, the implementation of the ≥1-mm tumor-free margin criterion would save a sizeable group of patients from surgery while maintaining oncological safety. Outcome data 15a Report numbers of outcome events or summary measures over time. 7,8,9
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included. Other analyses 17 Report other analyses done-eg, analyses of subgroups and interactions, and sensitivity analyses 9,10,11
Discussion
Key results 18 Summarise key results with reference to study objectives.
11,12
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias.
12,13
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence.
Generalisability 21 Discuss the generalisability (external validity) of the study results. 12,13
Other information Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based.
14 a provide information separately for exposed and unexposed groups
